A detailed history of Summit Financial Group, Inc. transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Summit Financial Group, Inc. holds 16,333 shares of EW stock, worth $1.09 Million. This represents 0.56% of its overall portfolio holdings.

Number of Shares
16,333
Previous 16,333 -0.0%
Holding current value
$1.09 Million
Previous $1.25 Million 25.3%
% of portfolio
0.56%
Previous 0.48%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 12, 2024

SELL
$61.71 - $77.76 $214,750 - $270,604
-3,480 Reduced 17.56%
16,333 $1.25 Million
Q3 2023

Oct 17, 2023

BUY
$69.28 - $93.38 $4,849 - $6,536
70 Added 0.35%
19,813 $1.37 Million
Q3 2022

Oct 12, 2022

BUY
$82.37 - $107.29 $5,189 - $6,759
63 Added 0.32%
19,743 $1.63 Million
Q2 2020

Jul 06, 2020

BUY
$57.54 - $76.95 $754,924 - $1.01 Million
13,120 Added 200.0%
19,680 $1.36 Million
Q3 2017

Oct 10, 2017

BUY
$36.29 - $38.83 $238,062 - $254,724
6,560
6,560 $717,000

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $41.1B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Summit Financial Group, Inc. Portfolio

Follow Summit Financial Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Summit Financial Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Summit Financial Group, Inc. with notifications on news.